3357 Introduction: The feasibility and significance of imaging pulmonary artery (PA)
remodeling with 68 Ga-fibroblast activating protein inhibitor (FAPI) in chronic …

Background The feasibility and significance of imaging pulmonary artery (PA) remodeling
with 68 Ga-fibroblast activating protein inhibitor (FAPI) in patients with chronic …

Correction: Pulmonary artery imaging with 68 Ga-FAPI-04 in patients with chronic
thromboembolic pulmonary hypertension Page 1 CORRECTION Correction: Pulmonary …

Background Positron emission tomography (PET) imaging with radiolabeled fibroblasts
activation protein inhibitor (FAPI) provides the opportunity to directly visualize fibrosis. This …

Purpose The aim of this study was to explore the association of cardiac fibroblast activation
with clinical parameters and cardiovascular magnetic resonance (CMR) imaging parameters …

Pulmonary arterial hypertension (PAH) is driven by pathologies associated with increased
metabolism such as pulmonary revascularization, vasoconstriction and smooth muscle cell …

Rationale. Inflammation plays an important role in PAH and macrophages are a key cell type
contributing to this process. While in vivo imaging of macrophages in PAH has been …

Background: Pulmonary vascular cell hyperproliferation is characteristic of pulmonary
vascular remodeling in pulmonary arterial hypertension. A noninvasive imaging biomarker is …

Rationale: Pulmonary arterial hypertension (PAH) is a proliferative arteriopathy associated
with glucose transporter-1 (Glut1) up-regulation and a glycolytic shift in lung metabolism …

The past decade has seen increased application of 18-flurodeoxyglucose positron emission
tomography (18FDG-PET) imaging to help diagnose and monitor disease, particularly in …